Table 3:
One-, 2- and 5-year survival probabilities by treatment modality and cohort, from Day 1 of the start of KRT, dialysis, or from the day of first kidney transplantation.
| Survival probabilities as percentage (95% CI) | |||||
|---|---|---|---|---|---|
| Cohort: 2011–15 | Cohort: 2014–18 | ||||
| Survival type | 1 year | 2 years | 5 years | 1 year | 2 years |
| Patient survival on KRT | |||||
| Unadjusted | 84.8 (84.6–85.0) | 74.8 (74.6–75.1) | 51.8 (51.6–52.0) | 85.5 (85.4–85.7) | 75.6 (75.4–75.8) |
| Adjusteda | 87.6 (87.4–87.7) | 78.5 (78.3–78.7) | 53.9 (53.6–54.2) | 88.1 (88.0–88.3) | 79.0 (78.8–79.2) |
| Patient survival on dialysis | |||||
| Unadjusted | 83.7 (83.5–83.9) | 72.2 (72.0–72.5) | 41.8 (41.5–42.1) | 84.5 (84.3–84.6) | 72.9 (72.7–73.1) |
| Adjusteda | 85.9 (85.8–86.1) | 75.6 (75.4–75.8) | 46.8 (46.5–47.1) | 86.8 (86.7–87.0) | 76.6 (76.4–76.8) |
| Patient survival after a first kidney transplantation (deceased donor) | |||||
| Unadjusted | 96.2 (96.0–96.4) | 94.1 (93.8–94.3) | 86.2 (85.8–86.5) | 96.3 (96.2–96.5) | 94.1 (93.9–94.3) |
| Adjustedb | 98.0 (97.9–98.1) | 96.8 (96.7–97.0) | 92.1 (91.9–92.4) | 98.1 (97.9–98.2) | 96.8 (96.7–97.0) |
| Graft survival after a first kidney transplantation (deceased donor) | |||||
| Unadjusted | 91.0 (90.7–91.3) | 87.9 (87.5–88.2) | 77.3 (76.9–77.7) | 91.3 (91.0–91.6) | 88.0 (87.7–88.4) |
| Adjustedb | 92.9 (92.6–93.1) | 90.3 (90.0–90.6) | 81.3 (80.9–81.8) | 93.1 (92.8–93.3) | 90.4 (90.1–90.7) |
| Patient survival after a first kidney transplantation (living donor) | |||||
| Unadjusted | 99.0 (98.8–99.1) | 98.1 (97.8–98.3) | 94.4 (94.0–94.8) | 98.9 (98.7–99.0) | 98.0 (97.8–98.3) |
| Adjustedb | 99.1 (98.9–99.3) | 98.3 (98.1–98.5) | 95.0 (94.6–95.4) | 99.1 (98.9–99.2) | 98.4 (98.1–98.6) |
| Graft survival after a first kidney transplantation (living donor) | |||||
| Unadjusted | 96.6 (96.3–97.0) | 94.9 (94.5–95.3) | 88.1 (87.5–88.7) | 96.7 (96.3–97.0) | 95.2 (94.8–95.5) |
| Adjustedb | 96.4 (96.0–96.7) | 94.5 (94.1–95.0) | 87.3 (86.6–87.9) | 96.5 (96.1–96.8) | 94.9 (94.5–95.3) |
aAnalyses were adjusted using fixed values: age (67 years), sex (63% men) and PRD (24% DM, 19% HT/RVD, 11% GN and 46% other causes)
bAnalyses were adjusted using fixed values: age (50 years), sex (63% men) and PRD (14% DM, 10% HT/RVD, 23% GN and 53% other causes)
This table is based on data from the following registries providing individual patient data: Austria, Belgium (Dutch-speaking), Belgium (French-speaking), Bosnia and Herzegovina, Denmark, Estonia, Finland, France, Greece, Iceland, Norway, Spain (Andalusia), Spain (Aragon), Spain (Asturias), Spain (Basque country), Spain (Cantabria), Spain (Castile and León), Spain (Castile-La Mancha), Spain (Catalonia), Spain (Community of Madrid), Spain (Extremadura), Spain (Galicia), Spain (Murcia), Spain (Valencian Region), Sweden, the Netherlands, the UK (England/Northern Ireland/Wales) and the UK (Scotland).